Thomas F. Gajewski to Benzimidazoles
This is a "connection" page, showing publications Thomas F. Gajewski has written about Benzimidazoles.
Connection Strength
0.244
-
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma. J Cancer Res Clin Oncol. 2017 Mar; 143(3):439-445.
Score: 0.132
-
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. JAMA. 2014 Jun 18; 311(23):2397-405.
Score: 0.112